MarketInOut Stock Screener Log In | Sign Up

Takeda Pharmaceutical Co Ltd

TSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 14:35
Takeda Pharmaceutical Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSE
Market Capitalization10,240,201 mln
Float1,596 mln
Earnings Date10/29/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.44
Borderline

1-Year Forecast

6,684.56
Modest upside

Relative Strength

96 / 100
Top performer

Debt / Equity

0.65
Moderate leverage

Pre-Tax Margin

-3%
Barely loss-making

Business Description

Takeda Pharmaceutical Company Limited is a global drug maker founded in 1781 and based in Chuo, Japan, with operations spanning North America, Europe, Asia, Latin America, Africa, and beyond. The company researches, develops, manufactures, and sells medicines across a range of treatment areas, including digestive health, rare diseases, cancer, vaccines, and mental health. Takeda markets numerous well-known drug brands and works alongside a broad network of biotech and pharmaceutical partners to bring new treatments to patients worldwide.

Key Fundamentals

EPS-106
ROE-2.22
RPS2,925
ROIC5.07
ROA-1.08
Interest Cover2.26
EBITDA, mln907,801
EV / EBITDA15.14
EV / EBIT74.23
Revenue, mln4,618,935
EV / Revenue2.97

Quote Details

Last 6,315.00
Change -92 (-1.44%)
Open 6,395.00
Volume 1,986,100
Turnover 12,542,221,312
Average Volume 4,178,072

Financial Ratios

Pre-Tax Profit Margin-3
Leverage Ratio2.07
Current Ratio1.14
Price / Book1.21
Price / Cash Flow11.20
Price / Free Cash Flow13.74
Debt / Equity0.65
Price / Sales1.99
PEG Ratio0.46

Financial Strength

Altman Z-Score1.1
Piotroski F-Score 4 / 9
Beneish M-Score-2.44
Price to Intrinsic Value0.70
1-Year Target Price6,684.56
Shiller PE Ratio42.91

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 65 / 100   
1 Month 8.35% 94 / 100   
2 Months 20.2% 90 / 100   
6 Months 17.07% 83 / 100   
1 Year 54.61% 87 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog